Drug Type Non-recombinant coagulation factor |
Synonyms Alphanate, Factor VIII/von Willebrand factor, Fanhdi + [1] |
Target |
Mechanism F10 stimulants(Coagulation factor X stimulants), Blood coagulation pathway activation, Coagulation factor VIII replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (15 Aug 1978), |
RegulationOrphan Drug (US) |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Antihemophilic factor/von Willebrand factor complex(Grifols SA) | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hemophilia A | US | 17 Dec 1998 | |
Factor 8 Deficiency, Acquired | US | 15 Aug 1978 | |
Von Willebrand Diseases | US | - | 15 Aug 1978 |
Phase 2 | 2 | bzfforosvy(ointrwaheg) = vjnofudofa khvkqqrpry (uqmdxagdms, roptxmunda - ixdkbmhknc) View more | - | 23 Nov 2021 | |||
Not Applicable | - | ugvhhwysjb(itugtzbkiw) = nafsvzvekp vwnoypctfp (hffcmowdyb ) View more | Positive | 12 Jul 2020 |